ENSG vs. CPRX
Compare and contrast key facts about The Ensign Group, Inc. (ENSG) and Catalyst Pharmaceuticals, Inc. (CPRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ENSG or CPRX.
Correlation
The correlation between ENSG and CPRX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ENSG vs. CPRX - Performance Comparison
Key characteristics
ENSG:
0.89
CPRX:
0.85
ENSG:
1.40
CPRX:
1.39
ENSG:
1.17
CPRX:
1.18
ENSG:
1.32
CPRX:
0.92
ENSG:
4.21
CPRX:
3.50
ENSG:
4.60%
CPRX:
9.83%
ENSG:
21.66%
CPRX:
40.24%
ENSG:
-55.57%
CPRX:
-94.25%
ENSG:
-14.70%
CPRX:
-9.74%
Fundamentals
ENSG:
$8.02B
CPRX:
$2.63B
ENSG:
$4.13
CPRX:
$1.18
ENSG:
33.90
CPRX:
18.70
ENSG:
1.52
CPRX:
0.00
ENSG:
$4.08B
CPRX:
$460.48M
ENSG:
$569.89M
CPRX:
$379.07M
ENSG:
$364.01M
CPRX:
$192.55M
Returns By Period
In the year-to-date period, ENSG achieves a 19.45% return, which is significantly lower than CPRX's 28.49% return. Over the past 10 years, ENSG has underperformed CPRX with an annualized return of 20.75%, while CPRX has yielded a comparatively higher 22.05% annualized return.
ENSG
19.45%
-8.55%
10.38%
18.37%
24.90%
20.75%
CPRX
28.49%
0.56%
40.35%
30.28%
40.23%
22.05%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ENSG vs. CPRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for The Ensign Group, Inc. (ENSG) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ENSG vs. CPRX - Dividend Comparison
ENSG's dividend yield for the trailing twelve months is around 0.18%, while CPRX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG The Ensign Group, Inc. | 0.18% | 0.21% | 0.24% | 0.25% | 0.28% | 0.40% | 0.47% | 0.78% | 0.73% | 0.97% | 0.57% | 0.60% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ENSG vs. CPRX - Drawdown Comparison
The maximum ENSG drawdown since its inception was -55.57%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for ENSG and CPRX. For additional features, visit the drawdowns tool.
Volatility
ENSG vs. CPRX - Volatility Comparison
The current volatility for The Ensign Group, Inc. (ENSG) is 4.21%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 9.00%. This indicates that ENSG experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ENSG vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between The Ensign Group, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities